Acquisition of Tippecanoe Laboratories in USA completed

Essen, (PresseBox) - Evonik Industries AG has completed the purchase of the Tippecanoe Laboratories manufacturing facility in Lafayette (Indiana, USA) from Eli Lilly and Company, Indianapolis (USA). The deal was closed on January 1, 2010. It was agreed not to disclose details of the purchase price.

The site has a workforce of some 650 and produces active ingredients and intermediates for the pharmaceuticals industry.
The deal includes a longterm partnership with Lilly for the production of active ingredients and a multiyear supply agreement for active ingredients and intermediates for pharmaceuticals. The site will be fully integrated into Evonik's global production and marketing network.

The purchase of the site strengthens Evonik's exclusive synthesis business in the USA and offers scope for further longterm growth.

Evonik Industries AG

Evonik Industries is the creative industrial group from Germany which operates in three business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous selfrenewal, and reliability.

Evonik is active in over 100 countries around the world. In its fiscal year 2008 about 41,000 employees generated sales of about €15.9 billion and an operating profit (EBITDA) of about €2.2 billion.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.